Published in J Clin Endocrinol Metab on October 09, 2007
Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev (2009) 9.60
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol (2011) 3.02
Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2013) 2.43
Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol (2011) 2.28
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev (2012) 2.22
Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2009) 2.08
Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertil Steril (2008) 1.60
Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol (2013) 1.60
The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. J Clin Endocrinol Metab (2008) 1.18
Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol (2009) 1.14
Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome. J Clin Endocrinol Metab (2008) 1.08
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev (2015) 1.06
Developmental programming: excess weight gain amplifies the effects of prenatal testosterone excess on reproductive cyclicity--implication for polycystic ovary syndrome. Endocrinology (2008) 1.02
Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. J Clin Endocrinol Metab (2013) 1.01
Polycystic ovary syndrome: an ancient disorder? Fertil Steril (2010) 0.99
Reproductive health of women electing bariatric surgery. Fertil Steril (2009) 0.95
Obesity and PCOS: implications for diagnosis and treatment. Semin Reprod Med (2012) 0.94
Cognitive-behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: a pilot study. J Pediatr Psychol (2008) 0.93
Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation. Diabetes Metab Syndr Obes (2010) 0.92
Ontogeny of the ovary in polycystic ovary syndrome. Fertil Steril (2013) 0.92
Ovarian cycle-specific regulation of adipose tissue lipid storage by testosterone in female nonhuman primates. Endocrinology (2013) 0.90
State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS). Int J Pediatr Endocrinol (2011) 0.90
Parents' Readiness to Change Affects BMI Reduction Outcomes in Adolescents with Polycystic Ovary Syndrome. J Obes (2012) 0.89
Childhood obesity and its impact on the development of adolescent PCOS. Semin Reprod Med (2014) 0.89
The association between hyperandrogenemia and the metabolic syndrome in morbidly obese women. Diabetol Metab Syndr (2015) 0.83
Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}. J Clin Endocrinol Metab (2010) 0.83
Interaction between common variants of FTO and MC4R is associated with risk of PCOS. Reprod Biol Endocrinol (2015) 0.82
Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome. Endocrine (2012) 0.82
Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation. PLoS One (2012) 0.81
Polycystic ovary syndrome is a family affair. J Clin Endocrinol Metab (2008) 0.79
Potential effects of aerobic exercise on the expression of perilipin 3 in the adipose tissue of women with polycystic ovary syndrome: a pilot study. Eur J Endocrinol (2014) 0.79
Polycystic ovary syndrome is associated with an increased prevalence of irritable bowel syndrome. Dig Dis Sci (2009) 0.79
Effect of maternal PCOS and PCOS-like phenotype on the offspring's health. Mol Cell Endocrinol (2015) 0.78
Anthropometric characteristics and dietary pattern of women with polycystic ovary syndrome. Indian J Endocrinol Metab (2013) 0.78
Menstrual concerns and intrauterine contraception among adolescent bariatric surgery patients. J Womens Health (Larchmt) (2011) 0.78
Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity. Obstet Gynecol Int (2012) 0.78
Hyperandrogenism Does Not Influence Metabolic Parameters in Adolescent Girls with PCOS. Int J Endocrinol (2012) 0.77
The characterization of obese polycystic ovary syndrome rat model suitable for exercise intervention. PLoS One (2014) 0.77
Obesity, polycystic ovarian syndrome and thyroid dysfunction in women with epilepsy. Ann Indian Acad Neurol (2012) 0.77
Pharmacological treatment of obesity in patients with polycystic ovary syndrome. J Obes (2010) 0.77
Voluntary Exercise Improves Estrous Cyclicity in Prenatally Androgenized Female Mice Despite Programming Decreased Voluntary Exercise: Implications for Polycystic Ovary Syndrome (PCOS). Endocrinology (2015) 0.76
Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study. J Ovarian Res (2015) 0.75
Pathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndrome. Int J Womens Health (2016) 0.75
Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review. Fertil Res Pract (2016) 0.75
Effect of green tea on metabolic and hormonal aspect of polycystic ovarian syndrome in overweight and obese women suffering from polycystic ovarian syndrome: A clinical trial. J Educ Health Promot (2017) 0.75
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser (2000) 70.59
The obesity epidemic in the United States--gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev (2007) 16.67
The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab (2004) 7.96
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab (1998) 4.63
A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab (2000) 3.94
A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab (1999) 3.24
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab (2001) 2.66
Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab (2004) 2.66
Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine (2006) 2.61
Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod (1995) 1.87
Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod (1998) 1.85
Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol (1987) 1.81
Obesity and androgens: facts and perspectives. Fertil Steril (2006) 1.78
PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG (2006) 1.77
Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab (2005) 1.76
Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) (2006) 1.76
Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod (1995) 1.75
Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev (2003) 1.69
Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxf) (1999) 1.60
Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance. Hum Reprod (2004) 1.58
The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril (2006) 1.56
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril (2002) 1.55
Polycystic ovary syndrome and endometrial carcinoma. Lancet (2003) 1.43
Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med (2006) 1.27
Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril (1999) 1.12
Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab (2005) 1.10
Measurement of total serum testosterone levels using commercially available kits: high degree of between-kit variability. Fertil Steril (1998) 1.09
Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea. Metabolism (2006) 1.04
Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med (2006) 1.01
Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. Hum Reprod (2006) 0.99
Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. Hum Reprod (2004) 0.90
Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia. Horm Metab Res (2005) 0.89
Decreased soluble leptin receptor levels in women with polycystic ovary syndrome. Eur J Endocrinol (2006) 0.88
Chronic hyperinsulinemia and the adrenal androgen response to acute corticotropin-(1-24) stimulation in hyperandrogenic women. Am J Obstet Gynecol (1995) 0.88
Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation. J Clin Endocrinol Metab (1995) 0.86
Genetic and environmental origins of obesity relevant to reproduction. Reprod Biomed Online (2006) 0.85
Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens. Fertil Steril (2006) 0.85
Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol (2004) 0.85
Elevated serum TNF-alpha levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome. J Reprod Med (2003) 0.85
Lifestyle choices, diet, and insulin sensitizers in polycystic ovary syndrome. Endocrine (2006) 0.82
The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab (2004) 7.96
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 3.80
Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab (2006) 3.46
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol (2011) 3.02
Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 2.28
Retracted Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab (2008) 2.21
Use of metformin in polycystic ovary syndrome. Am J Obstet Gynecol (2008) 1.92
Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril (2005) 1.82
Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab (2006) 1.56
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril (2002) 1.55
Laparoscopic evaluation following failure to achieve pregnancy after ovulation induction with clomiphene citrate. Fertil Steril (2003) 1.51
Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet (2011) 1.51
The severity of menstrual dysfunction as a predictor of insulin resistance in PCOS. J Clin Endocrinol Metab (2013) 1.50
Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome. Fertil Steril (2008) 1.49
Reproductive hormone exposure timing and ischemic heart disease: Complicated answers to a simple question. Maturitas (2010) 1.39
Fifteen-year trend in the use of male reproductive surgery: analysis of the healthcare cost and utilization project data. BJU Int (2011) 1.39
Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril (2005) 1.34
Socioeconomic and racial predictors of undergoing laparoscopic hysterectomy for selected benign diseases: analysis of 341487 hysterectomies. J Minim Invasive Gynecol (2008) 1.33
Visually scoring hirsutism. Hum Reprod Update (2009) 1.21
Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women. J Clin Endocrinol Metab (2006) 1.19
Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated. J Clin Epidemiol (2004) 1.18
Nonclassic congenital adrenal hyperplasia. Int J Pediatr Endocrinol (2010) 1.17
Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) (2005) 1.17
miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance. Diabetes (2013) 1.17
FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. PLoS One (2011) 1.16
Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab (2006) 1.13
Novel pathway of adipogenesis through cross-talk between adipose tissue macrophages, adipose stem cells and adipocytes: evidence of cell plasticity. PLoS One (2011) 1.12
Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril (2009) 1.10
The adrenal and polycystic ovary syndrome. Rev Endocr Metab Disord (2007) 1.09
Diagnosis of polycystic ovary syndrome. Clin Obstet Gynecol (2007) 1.08
Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. J Clin Endocrinol Metab (2008) 1.06
Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2004) 1.06
From the eye of the nurses: 360-degree evaluation of residents. J Contin Educ Health Prof (2009) 1.04
Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertil Steril (2006) 1.03
Congenital adrenal hyperplasia. J Pediatr Adolesc Gynecol (2011) 1.03
Defining hirsutism in Chinese women: a cross-sectional study. Fertil Steril (2011) 1.01
Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation. Fertil Steril (2009) 1.01
Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. J Clin Endocrinol Metab (2013) 1.01
Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys. PLoS One (2011) 1.00
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). J Womens Health (Larchmt) (2009) 1.00
Difference in dietary intake between women with polycystic ovary syndrome and healthy controls. Fertil Steril (2006) 1.00
Reanalyzing the modified Ferriman-Gallwey score: is there a simpler method for assessing the extent of hirsutism? Fertil Steril (2011) 0.97
Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS. Fertil Steril (2008) 0.96
Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 0.96
The age-associated decline of androgens in reproductive age and menopausal Black and White women. J Clin Endocrinol Metab (2007) 0.95
Role of diet in the treatment of polycystic ovary syndrome. Fertil Steril (2006) 0.95
Nonreplication of the type 5 17beta-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 0.94
Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome. Fertil Steril (2011) 0.94
A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency. Int J Pediatr Endocrinol (2010) 0.94
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study. J Clin Endocrinol Metab (2005) 0.93
The Associations Between Residents' Behavior and the Thomas-Kilmann Conflict MODE Instrument. J Grad Med Educ (2010) 0.93
Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease. J Clin Endocrinol Metab (2008) 0.93
First evidence of genetic association between AKT2 and polycystic ovary syndrome. Diabetes Care (2008) 0.93
Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome. J Clin Endocrinol Metab (2012) 0.92
Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals. J Clin Endocrinol Metab (2015) 0.92
Laser hair reduction in the hirsute patient: a critical assessment. Hum Reprod Update (2002) 0.91
Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2009) 0.91
A pilot randomized, single-blind, placebo-controlled trial of traditional acupuncture for vasomotor symptoms and mechanistic pathways of menopause. Menopause (2012) 0.90
Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene. J Clin Endocrinol Metab (2009) 0.90
DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE). J Clin Endocrinol Metab (2010) 0.89
Diagnosing the diagnosis: why we must standardize the defining features of polycystic ovary syndrome. Ann Clin Biochem (2008) 0.89
Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOS. Clin Endocrinol (Oxf) (2013) 0.89
Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3. Fertil Steril (2008) 0.89
Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance. Fertil Steril (2005) 0.89
Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome. Fertil Steril (2006) 0.89
Preliminary evidence of glycogen synthase kinase 3 beta as a genetic determinant of polycystic ovary syndrome. Fertil Steril (2007) 0.88
Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis. Mol Hum Reprod (2012) 0.87
Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome. Fertil Steril (2004) 0.86
Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome. Fertil Steril (2011) 0.86
Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative. Int J Pediatr Endocrinol (2011) 0.86
Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters. Fertil Steril (2006) 0.86
Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess. Fertil Steril (2004) 0.86
The prevalence of androgen excess among patients with minimal unwanted hair growth. Am J Obstet Gynecol (2004) 0.84
Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling. J Clin Endocrinol Metab (2002) 0.83
Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome. J Clin Endocrinol Metab (2004) 0.83
Resistin stimulation of 17alpha-hydroxylase activity in ovarian theca cells in vitro: relevance to polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 0.83
Effect of oral estrogen on substrate utilization in postmenopausal women. Fertil Steril (2007) 0.83
Promoting residents' professional development and academic productivity using a structured faculty mentoring program. Teach Learn Med (2010) 0.83
Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS). Steroids (2011) 0.83
Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-{alpha}. J Clin Endocrinol Metab (2010) 0.83
Socioeconomic status and polycystic ovary syndrome. J Womens Health (Larchmt) (2011) 0.83
Correlation of adrenocorticotropin steroid levels between women with polycystic ovary syndrome and their sisters. Am J Obstet Gynecol (2007) 0.82
Family size in women with polycystic ovary syndrome. Fertil Steril (2006) 0.82
Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone. J Clin Endocrinol Metab (2003) 0.82
Effect of insulin and testosterone on androgen production and transcription of SULT2A1 in the NCI-H295R adrenocortical cell line. Fertil Steril (2008) 0.81
Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome. Fertil Steril (2004) 0.81
Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome. Hum Reprod (2014) 0.81
The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: a report from the Los Angeles Atherosclerosis Study. J Clin Endocrinol Metab (2010) 0.81
Reproducibility of the adrenal androgen response to adrenocorticotropic hormone stimulation. Fertil Steril (2006) 0.81
The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia. Fertil Steril (2009) 0.80
Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2008) 0.80
Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility. J Clin Endocrinol Metab (2012) 0.80
Effects of endogenous androgens and abdominal fat distribution on the interrelationship between insulin and non-insulin-mediated glucose uptake in females. J Clin Endocrinol Metab (2013) 0.79
Polycystic ovary syndrome is associated with an increased prevalence of irritable bowel syndrome. Dig Dis Sci (2009) 0.79
Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society. Fertil Steril (2009) 0.79
Polycystic ovary syndrome is a family affair. J Clin Endocrinol Metab (2008) 0.79
Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome. Ther Clin Risk Manag (2008) 0.79
Effect of oral micronized progesterone on androgen levels in women with polycystic ovary syndrome. Fertil Steril (2002) 0.79